Correlation Between FrontView REIT, and HEMOGENYX PHARMPLC

Can any of the company-specific risk be diversified away by investing in both FrontView REIT, and HEMOGENYX PHARMPLC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining FrontView REIT, and HEMOGENYX PHARMPLC into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between FrontView REIT, and HEMOGENYX PHARMPLC LS 01, you can compare the effects of market volatilities on FrontView REIT, and HEMOGENYX PHARMPLC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in FrontView REIT, with a short position of HEMOGENYX PHARMPLC. Check out your portfolio center. Please also check ongoing floating volatility patterns of FrontView REIT, and HEMOGENYX PHARMPLC.

Diversification Opportunities for FrontView REIT, and HEMOGENYX PHARMPLC

-0.43

Correlation Coefficient

FrontView REIT,  HEMOGENYX PHARMPLC

Very good diversification

The 3 months correlation between FrontView and HEMOGENYX is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding FrontView REIT, and HEMOGENYX PHARMPLC LS 01 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on HEMOGENYX PHARMPLC and FrontView REIT, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on FrontView REIT, are associated (or correlated) with HEMOGENYX PHARMPLC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of HEMOGENYX PHARMPLC has no effect on the direction of FrontView REIT, i.e., FrontView REIT, and HEMOGENYX PHARMPLC go up and down completely randomly.

Pair Corralation between FrontView REIT, and HEMOGENYX PHARMPLC

Considering the 90-day investment horizon FrontView REIT, is expected to under-perform the HEMOGENYX PHARMPLC. But the stock apears to be less risky and, when comparing its historical volatility, FrontView REIT, is 88.96 times less risky than HEMOGENYX PHARMPLC. The stock trades about -0.04 of its potential returns per unit of risk. The HEMOGENYX PHARMPLC LS 01 is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest  440.00  in HEMOGENYX PHARMPLC LS 01 on September 21, 2024 and sell it today you would lose (62.00) from holding HEMOGENYX PHARMPLC LS 01 or give up 14.09% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	90.63%
Values	Daily Returns

FrontView REIT,  vs.  HEMOGENYX PHARMPLC LS 01

FrontView REIT,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days FrontView REIT, has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, FrontView REIT, is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

HEMOGENYX PHARMPLC

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in HEMOGENYX PHARMPLC LS 01 are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, HEMOGENYX PHARMPLC reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with FrontView REIT, and HEMOGENYX PHARMPLC

The main advantage of trading using opposite FrontView REIT, and HEMOGENYX PHARMPLC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if FrontView REIT, position performs unexpectedly, HEMOGENYX PHARMPLC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HEMOGENYX PHARMPLC will offset losses from the drop in HEMOGENYX PHARMPLC's long position.

The idea behind FrontView REIT, and HEMOGENYX PHARMPLC LS 01 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.